Oculis Holding Financials
| OCS Stock | 16.16 0.79 5.14% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 5.2921 |
|
|
The essential information of the day-to-day investment outlook for Oculis Holding includes many different criteria found on its balance sheet. An individual investor should monitor Oculis Holding's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Oculis Holding.
Net Income |
|
Oculis | Select Account or Indicator |
Understanding current and past Oculis Holding Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Oculis Holding's financial statements are interrelated, with each one affecting the others. For example, an increase in Oculis Holding's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Oculis Holding's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Oculis Holding AG. Check Oculis Holding's Beneish M Score to see the likelihood of Oculis Holding's management manipulating its earnings.
Oculis Holding Stock Summary
Oculis Holding competes with Cue Biopharma, Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, and Molecular Partners. Oculis Holding is entity of United States. It is traded as Stock on NASDAQ exchange.| Foreign Associate | Iceland |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | G3167F102 H5870P102 |
| Location | Switzerland |
| Business Address | Bahnhofstrasse 7, Zug, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | oculis.com |
| Phone | 41 41 711 9325 |
Oculis Holding Key Financial Ratios
| Return On Equity | -0.69 | ||||
| Operating Margin | (83.94) % | ||||
| Price To Sales | 780.91 X | ||||
| Revenue | 883 K | ||||
| Gross Profit | (21.31 M) |
Oculis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Oculis Holding's current stock value. Our valuation model uses many indicators to compare Oculis Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oculis Holding competition to find correlations between indicators driving Oculis Holding's intrinsic value. More Info.Oculis Holding AG is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers . At this time, Oculis Holding's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Oculis Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Oculis Holding AG Systematic Risk
Oculis Holding's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Oculis Holding volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Oculis Holding AG correlated with the market. If Beta is less than 0 Oculis Holding generally moves in the opposite direction as compared to the market. If Oculis Holding Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Oculis Holding AG is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Oculis Holding is generally in the same direction as the market. If Beta > 1 Oculis Holding moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Oculis Holding Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Oculis Holding's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Oculis Holding growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Oculis Holding November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Oculis Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oculis Holding AG. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oculis Holding AG based on widely used predictive technical indicators. In general, we focus on analyzing Oculis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oculis Holding's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.91 | |||
| Information Ratio | 0.1166 | |||
| Maximum Drawdown | 24.36 | |||
| Value At Risk | (3.82) | |||
| Potential Upside | 5.74 |
Additional Tools for Oculis Stock Analysis
When running Oculis Holding's price analysis, check to measure Oculis Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oculis Holding is operating at the current time. Most of Oculis Holding's value examination focuses on studying past and present price action to predict the probability of Oculis Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oculis Holding's price. Additionally, you may evaluate how the addition of Oculis Holding to your portfolios can decrease your overall portfolio volatility.